Navigation Links
DURECT Announces ELADUR® (TRANSDUR®-Bupivacaine) Phase II Study Results in Chronic Low Back Pain
Date:4/11/2011

together to determine next steps."

About the DURECT / Pfizer Collaboration

In October 2008, DURECT signed a development and license agreement with Alpharma Ireland Limited (subsequently acquired by King Pharmaceuticals in December 2008 and King was subsequently acquired in February 2011 by Pfizer) whereby Alpharma was granted the exclusive worldwide rights to develop and commercialize ELADUR, an investigational bupivacaine patch.  Under the terms of the agreement, Alpharma paid DURECT an upfront license fee of $20 million, with possible additional payments of up to $93 million upon the achievement of predefined development and regulatory milestones spread over multiple clinical indications and geographical territories as well as possible additional payments of up to $150 million in sales-based milestones.  If ELADUR is commercialized, DURECT would also receive royalties on product sales.  Pfizer controls and funds any further development of the program.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR®, and ELADUR® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. F
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DURECT to Present at Cowen and Company Health Care Conference
2. DURECT Corporation Invites You to Join its Fourth Quarter 2010 Earnings Conference Call
3. DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR™ (SABER™-Bupivacaine) and Amendment of the Nycomed Agreement
4. DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product
5. DURECT to Present at the BIO CEO & Investor Conference
6. DURECT to Present at the Credit Suisse 2010 Healthcare Conference
7. DURECT Corporation Announces Third Quarter 2010 Financial Results
8. DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
9. DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
10. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
11. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Concord Medical ... (NYSE: CCM ), a leading specialty hospital ... network of radiotherapy and diagnostic imaging centers in ... signing of a purchase agreement under which Concord ... subsidiary of the Company, agreed to acquire the ...
(Date:3/27/2015)... March 27, 2015  WebMD Health Corp. ... of health information, today announced an exclusive ... National Action Plan for Combating Antibiotic-Resistant Bacteria ... the urgency and importance of addressing antibiotic-resistant ... global health.    The WebMD interview, ...
(Date:3/26/2015)... , March 26, 2015  The Burzynski Research ... study independently conducted by the Department of Surgery ... Japan have been published. The study, ... hepatic arterial infusion as post-operative adjuvant therapy with ... of the liver. A total ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... March 27, 2015 Smile Brands Inc. ... of business support services to dental groups in the ... affiliated Castle Dental office in Hendersonville, TN. ... TN 37075, this new Castle Dental office provides families ... the latest in comprehensive, quality dental care. Hendersonville marks ...
(Date:3/27/2015)... Yisrayl Hawkins, Pastor and Overseer at The ... to live in Peace is through the Laws of Peace ... this week. , The article titled, “Yahweh’s Way-The Great Difference” ... how straying away from the original biblical instructions has caused ... that has been created in the world is based on ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... a Quaker-based, philanthropic, grant-making foundation committed to raising ... behavioral healthcare is delivered. , The Scattergood Foundation ... advance Behavioral Health Policy and Practice through the ... SoundsLikeIBS Program App is designed to guide ...
(Date:3/26/2015)... Let’s not lose focus of why ... today’s traffic magnets. Three out of 4 consumers choose ... produce department, according to a Packaged Facts survey. Produce ... looking to add more fruits and vegetables to their ... is April 2. As featured in the Chase’s Calendar ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2
... June 22 With the outbreak of H1N1 influenza in ... vaccine, which can effectively prevent the disease from spreading. The ... become a hot topic around the world. In fact, the ... industry in China and globally for quite some time now. ...
... Families by Killing 99.9% of Illness-Causing Bacteria on Soft Surfaces , ... be the only ones getting comfy and cozy on the sofa. ... home can harbor thousands of bacteria. In fact, if fabric ... on them for months.(1) , , Families now have ...
... has found that Caucasians are much more likely than people ... soft tissue cancer called Ewing,s sarcoma. In addition, among Caucasians ... women. Published in the August 1, 2009 issue of ... the study indicates that examining the gender and racial differences ...
... - Donating blood today will help save lives , ... and its divisions in Manhattan, Long Island, Hudson Valley, Brooklyn / ... donate blood in advance of the July 4th holiday weekend. ... "trauma season" for most emergency rooms. According to the Centers ...
... transplant recipients to suppress their immune systems, has a paradoxical ... Emory Vaccine Center have discovered. In experiments conducted in ... memory CD8 T cells, which enable the immune system to ... second encounter. The results were published online ahead of ...
... Pick shades with UV protection, and wear them a ... News) -- Price and style -- not protection from ... considerations when buying sunglasses, a new survey has found. ... the American Optometric Association, which conducted the survey. , ...
Cached Medicine News:Health News:Frost & Sullivan Sees Opportunities in Chinese Vaccine Industry 2Health News:Frost & Sullivan Sees Opportunities in Chinese Vaccine Industry 3Health News:Harmful Bacteria May Hide on Soft Surfaces in Your Home 2Health News:Caucasians are at higher risk of developing Ewing's sarcoma than other races 2Health News:Give Life for the Fourth of July 2Health News:Give Life for the Fourth of July 3Health News:Transplant drug stimulates immune memory 2Health News:Not All Sunglasses Are Created Equal 2
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, low viscosity bone cement for syringe use with an average setting time of approx. 7-9 Min., 41.6g of powder and 16.4g of liquid....
... Featuring new technology, such as a ... shaft and lens housings, this arthroscope has ... accomplished by EO, Steris and steam autoclaving ... diameters. Light post/adapters to fit ACMI, Wolf, ...
... The Passport II delivery device is the ... for C11UB. Its simple-to-use syringe technology allows ... a small incision. The blue colored plunger ... to protect the haptics during insertion. The ...
Medicine Products: